Response of metastatic acral melanoma with exon 11 BRAF G469A mutation to BRAF/MEK inhibition
J Dtsch Dermatol Ges
.
2022 Apr;20(4):528-530.
doi: 10.1111/ddg.14737.
Epub 2022 Feb 26.
Authors
Katharina Julius
1
,
Christian Kromer
1
,
Viktor Schnabel
1
,
Lyubomira Vlahova
1
,
Julia Kitz
2
,
Michael P Schön
1
3
,
Carsten-Oliver Sahlmann
4
,
Lutz Kretschmer
1
Affiliations
1
Department of Dermatology, Venereology, and Allergology, University Medical Center, Göttingen, Germany.
2
Institute of Pathology, University Medical Center, Göttingen, Germany.
3
Lower Saxony Institute of Occupational Dermatology, University Medical Center, Göttingen, Germany.
4
Institute of Nuclear Medicine, University Medical Center, Göttingen, Germany.
PMID:
35218304
DOI:
10.1111/ddg.14737
No abstract available
Publication types
Letter